Award notice, first published as sources sought
Award Notice - Sole Source Grifols Reagent Annual Drop Shipment (Procleix - Ultrio Elite, West Nile Virus, & Babesia) for U.S. Naval Hospital Okinawa, Japan
HT941024N0089
Defense Health Agency (Dha), Defense Health Agency HCD West. In-Vitro Diagnostic Substance Manufacturing.
Awarded
Grifols Diagnostic Solutions Inc.
$2,407,078.00 on the award notice, August 28, 2024, contract HT941024P0206
Get the next one like this from Defense Health Agency (Dha) by email, the day it is posted.Find my opportunities
This one was awarded in 2024
13 like it are open now in in-vitro diagnostic substance manufacturing
- NOI - DNA Sequencing of Bone Marrow Failure Syndro
National Institutes of Health, National Institutes of Health Olao
Combined synopsis and solicitationNAICS 325413Anywhere in the US75N98027Q00027Closes tomorrowNov 2 - HEMOCHRON SIGNATURE ELITE REAGENTS AND SUPPLIES
Department of Veterans Affairs, 262-Network Contract Office 22
Sources soughtNAICS 325413Anywhere in the US36C26227Q0046Closes tomorrowNov 2 - DRESSING, DRAWTEX 4IN X 4IN (VA-27-00014447)
Department of Veterans Affairs, National Cmop Office
Sources soughtNAICS 325413Anywhere in the US36C77027Q0015Closes in 2 daysNov 3
Description
As published on SAM.gov.
The Defense Health Agency, Contracting Office - San Diego (HT9410), 7700 Arlington Blvd., Falls Church, VA 22042, has awarded a firm-fixed price (FFP), supply contract. The supplies provide an annual dropshipment of Grifols Reagents (Ultrio Elite Assay, West Nile Virus Assay, and Babesia Assay) at U.S. Naval Hospital Okinawa (USNHO), Japan. This sole source and firm-fixed price contract was awarded to Grifols Diagnostic Solutions, Inc. on 28 August 2024 for a base plus four (4) option years. Total contract value is $2,407,078.00. The requirement was not awarded competitively because of exclusive licensing of supplies.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Grifols Diagnostic Solutions Inc.
- UEI
- R4N2Y6E9D6H7
- CAGE
- 7AJ96
- Vendor location
- Emeryville, CA
- Contract
- HT941024P0206, purchase order
- Obligated
- $711,317.00, current value $934,329, potential $2,407,078
- Actions
- 5 between August 28, 2024 and December 16, 2025
- Competition
- Not Competed Under SAP, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- Grifols Reagents - Procleix Ultrio Elite, West Nile Virus, & Babesia
- Match
- award number HT941024P0206 equals the contract number; same awarding office HT9410 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
June 26, 2024
Sources sought
Notice of Intent to Sole Source Grifols Reagent Annual Drop Shipment (Procleix - Ultrio Elite, West Nile Virus, & Babesia) for U.S. Naval Hospital Okinawa, Japan
Due June 28, 2024 at 8:00 PM EDT. SAM.gov, notice 0164b948803a4c09993a9b99420376d6
August 29, 2024
Award notice
Awarded to GRIFOLS DIAGNOSTIC SOLUTIONS Inc. Emeryville for $2,407,078. SAM.gov, notice 7b512e9e1ca64abd9b22855b8c2a3c92
Points of contact
- Adrian Neridaadrian.m.nerida.civ@health.mil
- Shannon La Comshannon.lacom2.civ@health.mil